Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks

May 5, 2016 1:45 AM UTC

Gene therapy company uniQure N.V. (NASDAQ:QURE) named Paul Firuta chief commercial officer. He was chief commercial officer at BioBlast Pharma Ltd. (NASDAQ:ORPN).

Metabolic company Orexigen Therapeutics Inc. (NASDAQ:OREX) named Brian Longstreet SVP of global market access and development. Longstreet was managing director of the Global Health Investment Fund at Merck & Co. Inc. (NYSE:MRK). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article